Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

被引:5
|
作者
Miguel Rivera-Caravaca, Jose [1 ]
Marin, Francisco [1 ]
Asuncion Esteve-Pastor, Maria [1 ]
Galvez, Josefa [2 ]
Lip, Gregory Y. H. [3 ,4 ,5 ]
Vicente, Vicente [2 ]
Roldan, Vanessa [2 ]
机构
[1] Univ Murcia, Hosp Clin Univ Virgen de la Arrixaca, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Cardiol,CIBERCV, Murcia, Spain
[2] Univ Murcia, Hosp Gen Univ Morales Meseguer, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Hematol & Clin Oncol, Murcia, Spain
[3] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[4] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[5] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
来源
BMJ OPEN | 2019年 / 9卷 / 12期
关键词
CLINICAL CLASSIFICATION SCHEMES; BLEEDING RISK-FACTORS; NATIONAL REGISTRY; PREDICTING STROKE; SCORE; ANTICOAGULATION; STRATIFICATION; HEMORRHAGE; WARFARIN; DEFINITION;
D O I
10.1136/bmjopen-2019-033712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of International Normalized Ratio (INR) 2.0-3.0 over 65%-70%. Unfortunately, the difficulties of maintaining an optimal level of anticoagulation and the complications of VKAs (particularly haemorrhagic ones), frequently lead to cessation of this therapy, which has been associated with higher risk of adverse events (AEs), including ischaemic stroke. Our aims are as follows: (1) to evaluate the quality of oral anticoagulation with VKAs, the prevalence of poor quality of anticoagulation, and to identify factors predisposing to poor quality anticoagulation; and (2) to identify patients who will stop OAC and to investigate what factors influence the decision of OAC withdrawal. Methods and analysis Prospective observational cohort study including outpatients newly diagnosed with AF and naive for OACs from July 2016 to June 2018 in an anticoagulation clinic. Patients with prosthetic heart valves, rheumatic mitral valves or valvular AF will be excluded. Follow-up will extend for up to 3 years. During this period, the INR results and changes in the anticoagulant therapy will be recorded, as well as all AEs, or any other information that would be relevant to the proper conduct of research. Ethics and dissemination All patients were informed about the nature and purpose of the study, and the protocol was approved by the Ethics Committee of Hospital General Universitario Morales Meseguer (reference: EST:20/16). This is an observational study focusing on 'real life' practice and therefore all treatments and follow-up will be performed in accordance to the routine clinical practice with no specific interventions or visits. The results of our study will be disseminated by presentations at national and international meetings, and publications in peer-reviewed journals.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] XANTUS, a prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    Postula, Marek
    Kosior, Dariusz
    KARDIOLOGIA POLSKA, 2015, 73 : 71 - 75
  • [22] A 10-Year Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients with Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
    Banerjee, Amitava
    Halimi, Jean M.
    Vourc'h, Patrick
    Andres, Christian R.
    Taillandier, Sophie
    Lip, Gregory Y.
    Fauchier, Laurent
    CIRCULATION, 2013, 127 (12)
  • [23] Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study
    Guo, Yutao
    Wang, Yutang
    Li, Xiaoying
    Shan, Zaoliang
    Shi, Xiangmin
    Xi, Guorong
    Lip, Gregory Y. H.
    BMJ OPEN, 2018, 8 (05):
  • [24] Progression in cognitively impaired patients with atrial fibrillation: An observational study
    Storti, Benedetta
    Brovelli, Francesco
    Pozzi, Federico Emanuele
    Zuffi, Alessandro
    Piatti, Marco
    Appollonio, Ildebrando
    Tremolizzo, Lucio
    Ferrarese, Carlo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 80 - 81
  • [25] Capsule Commentary on Rivera-Caravaca et al., Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
    Bethany T. Samuelson Bannow
    Journal of General Internal Medicine, 2018, 33 : 945 - 945
  • [26] Capsule Commentary on Rivera-Caravaca et al., Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
    Bannow, Bethany T. Samuelson
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (06) : 945 - 945
  • [27] The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project
    Shantsila, A.
    Fauchier, L.
    Bisson, A.
    Bodin, A.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1411 - 1411
  • [28] The pacemaker atrial fibrillation study: The effect of anti-atrial fibrillation pacing algorithms in patients with paroxysmal atrial fibrillation
    Silberbauer, J
    Boodhoo, L
    Arya, A
    Freemantle, N
    Hildick-Smith, D
    O'Nunain, S
    Lloyd, G
    Kamalvand, K
    O'Kane, P
    Patel, N
    Sulke, A
    HEART, 2006, 92 : A84 - A85
  • [29] Cerebral oxygen desaturation in patients with totally thoracoscopic ablation for atrial fibrillation A prospective observational study
    Li, Guohui
    Yang, Liqiao
    Sun, Yuan
    Shen, Sai'e
    MEDICINE, 2020, 99 (17) : E19599
  • [30] A Smartphone App to Improve Oral Anticoagulation Adherence in Patients With Atrial Fibrillation: Prospective Observational Study
    Senoo, Keitaro
    Miki, Tomonori
    Ohkura, Takashi
    Iwakoshi, Hibiki
    Nishimura, Tetsuro
    Shiraishi, Hirokazu
    Teramukai, Satoshi
    Matoba, Satoaki
    JMIR MHEALTH AND UHEALTH, 2022, 10 (01):